Encompass Health Corporation (EHC)

Encompass Health Corp experienced significant insider selling over the past ninety days, totaling approximately 26.4 million dollars in net value. Key executives, including the CEO and CFO, offloaded shares following a positive earnings report. Despite this divestment activity, the stock price has appreciated by 25.4 percent recently, reflecting strong market performance.
Ticker: EHC Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Encompass Health Corporation. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
358.67
Quantity 2,754 +26.1%
Value US$2,291,086
2.0
Price Andrew L Chief Accounting Officer Officer
Transaction date
Sale
Price
394.37
Quantity 58,041 -1.5%
Value US$784,935
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
449.82
Quantity 47,568
Value US$4,063,075
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
125.95
Quantity 8,906 -10.6%
Value US$1,121,711
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
125.38
Quantity 18,869 -27.2%
Value US$2,365,795
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
126.06
Quantity 1,579 -0.6%
Value US$199,049
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
125.46
Quantity 171,569 -38.9%
Value US$21,525,047
3.4
Mark Tarr Officer Officer
Transaction date
Proposed sale
Price
125.45
Quantity 173,148
Value US$21,722,175
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
125.95
Quantity 8,906
Value US$1,121,701
2.9
Douglas Coltharp Officer Officer
Transaction date
Proposed sale
Price
125.38
Quantity 18,869
Value US$2,365,701
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
107.28
Quantity 1 -0.0%
Value US$107
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
106.83
Quantity 27,693 -28.5%
Value US$2,958,443
2.9
Douglas Edward Coltharp Officer Officer
Transaction date
Proposed sale
Price
106.83
Quantity 27,694
Value US$2,958,629
3.0
Tuer Patrick William EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
104.56
Quantity 682 -2.7%
Value US$71,310
3.0
Patrick Tuer Officer Officer
Transaction date
Proposed sale
Price
104.56
Quantity 682
Value US$71,312
1.7
Fay Edmund Sr. Vice Pres. and Treasurer Officer
Transaction date
Sale
Price
107.00
Quantity 11,937 -11.8%
Value US$1,277,259
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
113.58
Quantity 213 -0.1%
Value US$24,193
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
113.09
Quantity 87,745 -18.9%
Value US$9,923,082
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
111.89
Quantity 6,057 -1.3%
Value US$677,718
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
110.92
Quantity 10,954 -2.3%
Value US$1,215,018
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
110.07
Quantity 15,584 -3.1%
Value US$1,715,331
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
108.80
Quantity 13,231 -2.6%
Value US$1,439,533
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
108.03
Quantity 16,216 -3.1%
Value US$1,751,814
3.4
Mark Tarr Officer Officer
Transaction date
Proposed sale
Price
111.59
Quantity 150,000
Value US$16,738,961
3.0
Tuer Patrick William EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
107.62
Quantity 2,804 -14.9%
Value US$301,766
3.0
Patrick Tuer Officer Officer
Transaction date
Proposed sale
Price
107.62
Quantity 2,804
Value US$301,755
3.0
Patrick Tuer Officer Officer
Transaction date
Proposed sale
Price
123.59
Quantity 1,020
Value US$126,062
3.0
Tuer Patrick William EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
123.59
Quantity 1,020 -5.1%
Value US$126,062
3.4
Mark Tarr Officer Officer
Transaction date
Proposed sale
Price
121.50
Quantity 118,384
Value US$14,383,656
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
121.53
Quantity 118,290 -18.3%
Value US$14,375,784
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
120.94
Quantity 94 -0.0%
Value US$11,368
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
116.61
Quantity 4,279 -26.4%
Value US$498,974
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
116.36
Quantity 3,934 -6.1%
Value US$457,760
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
115.51
Quantity 13,402 -17.3%
Value US$1,548,065
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
114.78
Quantity 26,239 -25.3%
Value US$3,011,712
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
114.79
Quantity 10,000 -11.1%
Value US$1,147,900
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
114.79
Quantity 14,858
Value US$1,705,539
2.9
Douglas Edward Coltharp Officer Officer
Transaction date
Proposed sale
Price
115.15
Quantity 43,575
Value US$5,017,565
2.0
Price Andrew L Chief Accounting Officer Officer
Transaction date
Sale
Price
98.29
Quantity 5,042 -6.8%
Value US$495,578
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
87.03
Quantity 98 -0.1%
Value US$8,529
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
86.33
Quantity 12,162 -8.2%
Value US$1,049,945
2.9
Douglas Coltharp Officer Officer
Transaction date
Proposed sale
Price
86.34
Quantity 12,260
Value US$1,058,520
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
85.02
Quantity 10,000 -35.0%
Value US$850,200
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
85.02
Quantity 10,000 -35.0%
Value US$850,200
CHIDSEY JOHN Officer Officer
Transaction date
Proposed sale
Price
85.39
Quantity 29,500
Value US$2,518,936
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
83.94
Quantity 14,543 -14.6%
Value US$1,220,739
1.9
Darby John Patrick EVP, Gen Counsel & Secretary Officer
Transaction date
Sale
Price
83.94
Quantity 14,543 -14.6%
Value US$1,220,739
1.9
John Patrick Darby Officer Officer
Transaction date
Proposed sale
Price
84.20
Quantity 14,543
Value US$1,224,520
3.0
CARMICHAEL GREG D Non-Executive Director
Transaction date
Purchase
Price
83.73
Quantity 2,000 +13.3%
Value US$167,460
3.0
CARMICHAEL GREG D Non-Executive Director
Transaction date
Purchase
Price
83.73
Quantity 2,000 +13.3%
Value US$167,460
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
83.27
Quantity 44,976 -7.5%
Value US$3,745,152
3.4
Mark J Tarr CEO
Transaction date
Proposed sale
Price
83.64
Quantity 44,976
Value US$3,761,792
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
63.39
Quantity 11,215 -8.8%
Value US$710,919
2.9
Douglas Edward Coltharp Officer Officer
Transaction date
Proposed sale
Price
63.39
Quantity 11,215
Value US$710,914
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Sale
Price
69.58
Quantity 8,294 -26.4%
Value US$577,097
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
71.06
Quantity 25,330 -4.8%
Value US$1,799,950
3.4
Mark J. Tarr Officer Officer
Transaction date
Proposed sale
Price
71.06
Quantity 25,330
Value US$1,799,945
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
60.78
Quantity 17,895 -25.2%
Value US$1,087,658
3.0
CARMICHAEL GREG D Non-Executive Director
Transaction date
Purchase
Price
54.67
Quantity 1,830 +21.0%
Value US$100,046
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
53.25
Quantity 20,449 -4.4%
Value US$1,088,909
3.1
O'Connor Kevin J. Non-Executive Director
Transaction date
Purchase
Price
66.48
Quantity 1,000 +41.1%
Value US$66,480
3.2
Williams Terrance Non-Executive Director
Transaction date
Purchase
Price
56.61
Quantity 354 +7.2%
Value US$20,040
2.0
Price Andrew L Chief Accounting Officer Officer
Transaction date
Sale
Price
81.40
Quantity 8,589 -11.9%
Value US$699,145
2.3
Charbonneau Elissa Joy Chief Medical Officer Officer
Transaction date
Planned sale
Price
75.22
Quantity 6,650 -24.8%
Value US$500,213
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
76.15
Quantity 490 -0.3%
Value US$37,314
2.9
COLTHARP DOUGLAS E EVP & Chief Financial Officer Officer
Transaction date
Sale
Price
75.73
Quantity 23,011 -12.7%
Value US$1,742,623
2.7
Jacobsmeyer Barbara Ann President, Inpatient Hospitals Officer
Transaction date
Sale
Price
64.73
Quantity 2,500 -5.3%
Value US$161,825
3.4
Tarr Mark J President & CEO Executive Director
Transaction date
Sale
Price
61.92
Quantity 26,132 -6.4%
Value US$1,618,093
1.8
CORRELL DONALD L Non-Executive Director
Transaction date
Sale
Price
59.04
Quantity 2,000 -2.8%
Value US$118,080
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
60.76
Quantity 8,083 +4.4%
Value US$491,123
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
59.95
Quantity 20,580 +12.6%
Value US$1,233,771
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
58.91
Quantity 41,607 +34.3%
Value US$2,451,068
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
58.09
Quantity 38,882 +47.1%
Value US$2,258,655
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
57.29
Quantity 10,738 +14.9%
Value US$615,180
3.9
Anthony April Kaye Bullock CEO & President, Home Health Officer
Transaction date
Purchase
Price
56.44
Quantity 4,410 +6.5%
Value US$248,900
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-01 2026-08-31 S Sale

EVP, Gen Counsel & Secretary

Officer
2,754 +26.1%
358.67
US$2,291,086
2,754 +26.1% 358.67 US$2,291,086
2026-09-01 2026-08-31 S Sale

Chief Accounting Officer

Officer
58,041 -1.5%
394.37
US$784,935
58,041 -1.5% 394.37 US$784,935
2026-08-31 2026-08-31 PrS Proposed sale

Officer

Officer
47,568
449.82
US$4,063,075
47,568 449.82 US$4,063,075
2026-08-11 2026-08-10 S Sale

EVP, Gen Counsel & Secretary

Officer
8,906 -10.6%
125.95
US$1,121,711
8,906 -10.6% 125.95 US$1,121,711
2026-08-11 2026-08-10 S Sale

EVP & Chief Financial Officer

Officer
18,869 -27.2%
125.38
US$2,365,795
18,869 -27.2% 125.38 US$2,365,795
2026-08-11 2026-08-10 S Sale

President & CEO

Executive Director
1,579 -0.6%
126.06
US$199,049
1,579 -0.6% 126.06 US$199,049
2026-08-11 2026-08-10 S Sale

President & CEO

Executive Director
171,569 -38.9%
125.46
US$21,525,047
171,569 -38.9% 125.46 US$21,525,047
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
173,148
125.45
US$21,722,175
173,148 125.45 US$21,722,175
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
8,906
125.95
US$1,121,701
8,906 125.95 US$1,121,701
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
18,869
125.38
US$2,365,701
18,869 125.38 US$2,365,701
2026-05-18 2026-05-15 S Sale

EVP & Chief Financial Officer

Officer
1 -0.0%
107.28
US$107
1 -0.0% 107.28 US$107
2026-05-18 2026-05-15 S Sale

EVP & Chief Financial Officer

Officer
27,693 -28.5%
106.83
US$2,958,443
27,693 -28.5% 106.83 US$2,958,443
2026-05-15 2026-05-15 PrS Proposed sale

Officer

Officer
27,694
106.83
US$2,958,629
27,694 106.83 US$2,958,629
2026-05-12 2026-05-11 S Sale

EVP, Chief Operating Officer

Officer
682 -2.7%
104.56
US$71,310
682 -2.7% 104.56 US$71,310
2026-05-11 2026-05-11 PrS Proposed sale

Officer

Officer
682
104.56
US$71,312
682 104.56 US$71,312
2026-03-10 2026-03-09 S Sale

Sr. Vice Pres. and Treasurer

Officer
11,937 -11.8%
107.00
US$1,277,259
11,937 -11.8% 107.00 US$1,277,259
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
213 -0.1%
113.58
US$24,193
213 -0.1% 113.58 US$24,193
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
87,745 -18.9%
113.09
US$9,923,082
87,745 -18.9% 113.09 US$9,923,082
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
6,057 -1.3%
111.89
US$677,718
6,057 -1.3% 111.89 US$677,718
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
10,954 -2.3%
110.92
US$1,215,018
10,954 -2.3% 110.92 US$1,215,018
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
15,584 -3.1%
110.07
US$1,715,331
15,584 -3.1% 110.07 US$1,715,331
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
13,231 -2.6%
108.80
US$1,439,533
13,231 -2.6% 108.80 US$1,439,533
2026-02-12 2026-02-11 S Sale

President & CEO

Executive Director
16,216 -3.1%
108.03
US$1,751,814
16,216 -3.1% 108.03 US$1,751,814
2026-02-11 2026-02-11 PrS Proposed sale

Officer

Officer
150,000
111.59
US$16,738,961
150,000 111.59 US$16,738,961
2026-02-10 2026-02-10 S Sale

EVP, Chief Operating Officer

Officer
2,804 -14.9%
107.62
US$301,766
2,804 -14.9% 107.62 US$301,766
2026-02-10 2026-02-10 PrS Proposed sale

Officer

Officer
2,804
107.62
US$301,755
2,804 107.62 US$301,755
2025-08-27 2025-08-27 PrS Proposed sale

Officer

Officer
1,020
123.59
US$126,062
1,020 123.59 US$126,062
2025-08-27 2025-08-27 S Sale

EVP, Chief Operating Officer

Officer
1,020 -5.1%
123.59
US$126,062
1,020 -5.1% 123.59 US$126,062
2025-05-20 2025-05-20 PrS Proposed sale

Officer

Officer
118,384
121.50
US$14,383,656
118,384 121.50 US$14,383,656
2025-05-20 2025-05-20 S Sale

President & CEO

Executive Director
118,290 -18.3%
121.53
US$14,375,784
118,290 -18.3% 121.53 US$14,375,784
2025-05-20 2025-05-20 S Sale

President & CEO

Executive Director
94 -0.0%
120.94
US$11,368
94 -0.0% 120.94 US$11,368
2025-05-07 2025-05-06 S Sale

Chief Medical Officer

Officer
4,279 -26.4%
116.61
US$498,974
4,279 -26.4% 116.61 US$498,974
2025-04-30 2025-04-29 S Sale

EVP & Chief Financial Officer

Officer
3,934 -6.1%
116.36
US$457,760
3,934 -6.1% 116.36 US$457,760
2025-04-30 2025-04-29 S Sale

EVP & Chief Financial Officer

Officer
13,402 -17.3%
115.51
US$1,548,065
13,402 -17.3% 115.51 US$1,548,065
2025-04-30 2025-04-29 S Sale

EVP & Chief Financial Officer

Officer
26,239 -25.3%
114.78
US$3,011,712
26,239 -25.3% 114.78 US$3,011,712
2025-04-30 2025-04-29 S Sale

EVP, Gen Counsel & Secretary

Officer
10,000 -11.1%
114.79
US$1,147,900
10,000 -11.1% 114.79 US$1,147,900
2025-04-29 2025-04-29 PrS Proposed sale

Officer

Officer
14,858
114.79
US$1,705,539
14,858 114.79 US$1,705,539
2025-04-29 2025-04-29 PrS Proposed sale

Officer

Officer
43,575
115.15
US$5,017,565
43,575 115.15 US$5,017,565
2025-02-13 2025-02-13 S Sale

Chief Accounting Officer

Officer
5,042 -6.8%
98.29
US$495,578
5,042 -6.8% 98.29 US$495,578
2024-08-14 2024-08-13 S Sale

EVP & Chief Financial Officer

Officer
98 -0.1%
87.03
US$8,529
98 -0.1% 87.03 US$8,529
2024-08-14 2024-08-13 S Sale

EVP & Chief Financial Officer

Officer
12,162 -8.2%
86.33
US$1,049,945
12,162 -8.2% 86.33 US$1,049,945
2024-08-13 2024-08-13 PrS Proposed sale

Officer

Officer
12,260
86.34
US$1,058,520
12,260 86.34 US$1,058,520
2024-05-24 2024-05-24 S Sale

Chief Medical Officer

Officer
10,000 -35.0%
85.02
US$850,200
10,000 -35.0% 85.02 US$850,200
2024-05-24 2024-05-24 S Sale

Chief Medical Officer

Officer
10,000 -35.0%
85.02
US$850,200
10,000 -35.0% 85.02 US$850,200
2024-05-22 2024-05-22 PrS Proposed sale

Officer

Officer
29,500
85.39
US$2,518,936
29,500 85.39 US$2,518,936
2024-05-07 2024-05-06 S Sale

EVP, Gen Counsel & Secretary

Officer
14,543 -14.6%
83.94
US$1,220,739
14,543 -14.6% 83.94 US$1,220,739
2024-05-07 2024-05-06 S Sale

EVP, Gen Counsel & Secretary

Officer
14,543 -14.6%
83.94
US$1,220,739
14,543 -14.6% 83.94 US$1,220,739
2024-05-06 2024-05-06 PrS Proposed sale

Officer

Officer
14,543
84.20
US$1,224,520
14,543 84.20 US$1,224,520
2024-05-07 2024-05-03 B Purchase Non-Executive Director
2,000 +13.3%
83.73
US$167,460
2,000 +13.3% 83.73 US$167,460
2024-05-07 2024-05-03 B Purchase Non-Executive Director
2,000 +13.3%
83.73
US$167,460
2,000 +13.3% 83.73 US$167,460
2024-05-01 2024-04-30 S Sale

President & CEO

Executive Director
44,976 -7.5%
83.27
US$3,745,152
44,976 -7.5% 83.27 US$3,745,152
2024-04-30 2024-04-30 PrS Proposed sale

CEO

44,976
83.64
US$3,761,792
44,976 83.64 US$3,761,792
2023-11-14 2023-11-13 S Sale

EVP & Chief Financial Officer

Officer
11,215 -8.8%
63.39
US$710,919
11,215 -8.8% 63.39 US$710,919
2023-11-13 2023-11-13 PrS Proposed sale

Officer

Officer
11,215
63.39
US$710,914
11,215 63.39 US$710,914
2023-08-18 2023-08-17 S Sale

Chief Medical Officer

Officer
8,294 -26.4%
69.58
US$577,097
8,294 -26.4% 69.58 US$577,097
2023-08-17 2023-08-16 S Sale

President & CEO

Executive Director
25,330 -4.8%
71.06
US$1,799,950
25,330 -4.8% 71.06 US$1,799,950
2023-08-16 2023-08-16 PrS Proposed sale

Officer

Officer
25,330
71.06
US$1,799,945
25,330 71.06 US$1,799,945
2023-02-13 2023-02-10 S Sale

EVP & Chief Financial Officer

Officer
17,895 -25.2%
60.78
US$1,087,658
17,895 -25.2% 60.78 US$1,087,658
2022-11-01 2022-10-31 B Purchase Non-Executive Director
1,830 +21.0%
54.67
US$100,046
1,830 +21.0% 54.67 US$100,046
2022-08-19 2022-08-17 S Sale

President & CEO

Executive Director
20,449 -4.4%
53.25
US$1,088,909
20,449 -4.4% 53.25 US$1,088,909
2022-05-09 2022-05-06 B Purchase Non-Executive Director
1,000 +41.1%
66.48
US$66,480
1,000 +41.1% 66.48 US$66,480
2021-12-02 2021-12-02 B Purchase Non-Executive Director
354 +7.2%
56.61
US$20,040
354 +7.2% 56.61 US$20,040
2021-03-09 2021-03-08 S Sale

Chief Accounting Officer

Officer
8,589 -11.9%
81.40
US$699,145
8,589 -11.9% 81.40 US$699,145
2020-11-19 2020-11-17 PlS Planned sale

Chief Medical Officer

Officer
6,650 -24.8%
75.22
US$500,213
6,650 -24.8% 75.22 US$500,213
2020-05-29 2020-05-28 S Sale

EVP & Chief Financial Officer

Officer
490 -0.3%
76.15
US$37,314
490 -0.3% 76.15 US$37,314
2020-05-29 2020-05-28 S Sale

EVP & Chief Financial Officer

Officer
23,011 -12.7%
75.73
US$1,742,623
23,011 -12.7% 75.73 US$1,742,623
2020-05-18 2020-05-15 S Sale

President, Inpatient Hospitals

Officer
2,500 -5.3%
64.73
US$161,825
2,500 -5.3% 64.73 US$161,825
2020-05-14 2020-05-14 S Sale

President & CEO

Executive Director
26,132 -6.4%
61.92
US$1,618,093
26,132 -6.4% 61.92 US$1,618,093
2020-03-16 2020-03-12 S Sale Non-Executive Director
2,000 -2.8%
59.04
US$118,080
2,000 -2.8% 59.04 US$118,080
2020-03-13 2020-03-12 B Purchase

CEO & President, Home Health

Officer
8,083 +4.4%
60.76
US$491,123
8,083 +4.4% 60.76 US$491,123
2020-03-13 2020-03-12 B Purchase

CEO & President, Home Health

Officer
20,580 +12.6%
59.95
US$1,233,771
20,580 +12.6% 59.95 US$1,233,771
2020-03-13 2020-03-12 B Purchase

CEO & President, Home Health

Officer
41,607 +34.3%
58.91
US$2,451,068
41,607 +34.3% 58.91 US$2,451,068
2020-03-13 2020-03-12 B Purchase

CEO & President, Home Health

Officer
38,882 +47.1%
58.09
US$2,258,655
38,882 +47.1% 58.09 US$2,258,655
2020-03-13 2020-03-12 B Purchase

CEO & President, Home Health

Officer
10,738 +14.9%
57.29
US$615,180
10,738 +14.9% 57.29 US$615,180
2020-03-13 2020-03-12 B Purchase

CEO & President, Home Health

Officer
4,410 +6.5%
56.44
US$248,900
4,410 +6.5% 56.44 US$248,900